Short Interest in Merck KGaA (OTCMKTS:MKKGY) Increases By 234.9%

by · The Markets Daily

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 15th, there was short interest totaling 241,637 shares, an increase of 234.9% from the November 30th total of 72,150 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 280,839 shares, the days-to-cover ratio is currently 0.9 days. Based on an average daily trading volume, of 280,839 shares, the days-to-cover ratio is currently 0.9 days. Approximately 0.0% of the shares of the company are short sold.

Merck KGaA Stock Performance

Shares of MKKGY stock traded up $0.06 on Friday, hitting $28.51. 80,966 shares of the stock were exchanged, compared to its average volume of 114,320. The company has a current ratio of 1.49, a quick ratio of 0.97 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $18.42 billion, a PE ratio of 11.36, a P/E/G ratio of 5.71 and a beta of 0.97. Merck KGaA has a one year low of $24.32 and a one year high of $31.80. The firm’s 50 day moving average is $27.00 and its two-hundred day moving average is $26.34.

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) last released its quarterly earnings data on Thursday, November 13th. The company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.54 by $0.27. Merck KGaA had a net margin of 13.92% and a return on equity of 10.07%. The business had revenue of $6.17 billion for the quarter, compared to the consensus estimate of $6.08 billion. Sell-side analysts expect that Merck KGaA will post 1.87 earnings per share for the current fiscal year.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.

See Also